The risk assessment used in the patient clinician discussion should be entered 1) directly by EHR (eg, Epic, Cerner) or 2) by physician or other healthcare provider as part of documentation of the discussion. b. Patients should be knowledgeable about their results and, if interested, may be instructed on how to use the mobile ASCVD risk assessment app.139,140 Rationale Assessment of cardiovascular risk is the fundamental first step toward developing effective evidence-based therapy for treatment strategies for and shared decision discussions with patients. This includes using this assessment to correctly classify a patient s current stage of HBP in accordance with recommendations from the 2017 Hypertension Clinical Practice Guidelines.4 In general, the ACC/AHA race- and sex-specific PCE (ASCVD Risk Estimator139,140 ) should be used for screening and management of hypertension. The 10-y risk is used for patients without ASCVD who have stage 1 hypertension (130/80 139/89 mmHg) to determine those who should be treated with medical therapy (10-y risk >10%) and those who should who should be managed with nonpharmacological therapy (10-y risk <10%). Patients should know their current cardiovascular risk and how it relates to decisions about their therapy. 